Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Oct 4 - Oct 9
Hepatology , 40 (1), 6-9
Managing side effects well is the difference between successful treatment and discontinuation
Emraclidine, a novel positive allosteric modulator of cholinergic M4 receptors, for the treatment of schizophrenia: a two-part, randomised, double-blind, placebo-controlled, phase 1b trial
3.3 Multiple sclerosis Multiple sclerosis (MS) is an inflammation-mediated demyelinating disease of the human central nervous system, with neurodegeneration being the primary cause of irreversible neurological disability
US$ 24.80
US$ 27.35
US$ 23.02
US$ 25.69
US$ 22.32
US$ 25.11
US$ 27.80
US$ 21.89
US$ 23.28
US$ 21.34
